Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase NA 2Phase 2 2Phase 1 1

Status

Completed 6Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Breast Neoplasms 590Neoplasms 499Prostatic Neoplasms 316Lung Neoplasms 239Colorectal Neoplasms 201Motor Activity 134Carcinoma, Non-Small-Cell Lung 116Uterine Cervical Neoplasms 114Pancreatic Neoplasms 109Brain Neoplasms 109Head and Neck Neoplasms 104Stomach Neoplasms 100Rectal Neoplasms 98Carcinoma, Hepatocellular 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 68Esophageal Neoplasms 67Multiple Myeloma 65Hematologic Neoplasms 62Urinary Bladder Neoplasms 60Melanoma 59Sarcoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Glioblastoma 58Endometrial Neoplasms 57Glioma 53Anxiety Disorders 51Lymphoma 50Gastrointestinal Neoplasms 49

Interventions

pomalidomide 1Hyaluronoglucosaminidase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Amyloidosis × Clear all
NCT02641145 2025-11-14

MICA

Brigham and Women's Hospital

Phase NA Recruiting
171 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Cardiomyopathies

NCT06376214 2024-04-19

Daratumumab for Patients With Light Chain Amyloidosis

Nanjing University School of Medicine

Phase NA Recruiting
100 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡